Skip to main content
News Icon

Publication

Corona study published in Nature Communications

After the preliminary publication on the preprint server medRxiv in May 2020, the study by scientists of the University of Bonn about the first coronavirus outbreak in Germany in the community of Gangelt has been published in the renowned scientific journal Nature Communications.

The study was already pre-published in May 2020 to meet the demand of scientific journals to make findings about COVID-19 available to science and the public as early as possible.


Publication

Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event; Hendrik Streeck, Bianca Schulte, Beate M. Kümmerer, Enrico Richter, Tobias Höller, Christine Fuhrmann, Eva Bartok, Ramona Dolscheid, Moritz Berger, Lukas Wessendorf, Monika Eschbach-Bludau, Angelika Kellings, Astrid Schwaiger, Martin Coenen, Per Hoffmann, Birgit Stoffel-Wagner, Markus M. Nöthen, Anna-Maria Eis-Hübinger, Martin Exner, Ricarda Maria Schmithausen, Matthias Schmid and Gunther Hartmann; Nature Communications, DOI: http://dx.doi.org/10.1038/s41467-020-19509-y

The Cluster of Excellence ImmunoSensation2 provided no funding for the study.

Related news

News Icon

Publication

New vulnerability of asthma immune cells discovered

—Why do certain immune cells remain permanently active in allergic asthma – even in an environment that should actually damage them? A team from the University Hospital Bonn (UKB) and the University of Bonn has discovered that these cells only survive because they activate a special antioxidant protection mechanism. When this mechanism is blocked, allergic inflammation in mouse models decreases significantly. The results have now been published in the scientific journal Immunity.
View entry
The human P2X4 receptor

Publication

A starting point for the development of new pain and cancer drugs

—The human P2X4 receptor plays an important role in chronic pain, inflammation and some types of cancer. Researchers at the University of Bonn and the University Hospital Bonn (UKB) have now discovered a mechanism that can inhibit this receptor. The results were recently published in the scientific journal Nature Communications and open up a pathway for the development of new drugs. A study carried out by the University of Bonn and the University Hospital Bonn throws light on how P2X2 can be inhibited. The results have recently been published in Nature Communications.
View entry
Kato research group

Publication

Ominous false alarm in the kidney

—Bonn researchers have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering a chain reaction. In cooperation with Nanyang Technological University Singapore and the University Hospital Würzburg, among others, the study provides an explanation for how a point mutation in the immune receptor RIG-I transforms the body's defense system into a self-destructive force and causes severe organ-specific autoimmune diseases. The results have now been published in the journal Science Immunology.
View entry

Back to the news overview